Generation of five induced pluripotent stem cell lines from patients with MECP2 Duplication Syndrome

Area of Science:

• Genetics
• Neuroscience
• Stem Cell Biology

Background:

• MECP2 Duplication Syndrome (MDS) is a rare, severe neurodevelopmental disorder affecting males.
• It is caused by duplications in the Xq28 region, specifically involving the MECP2 gene.

Purpose of the Study:

• To generate and characterize human induced pluripotent stem cell (iPSC) lines from individuals with MECP2 Duplication Syndrome.
• To provide a valuable resource for studying the molecular and functional aspects of MDS.
• To facilitate the screening of potential therapeutic approaches for MDS.

Main Methods:

• Generated five human iPSC lines from patient fibroblasts with varying MECP2 duplication sizes (0.355–11.2 Mb).
• Confirmed MECP2 duplication in all generated cell lines.
• Assessed iPSC characteristics, including morphology, pluripotency markers, and trilineage differentiation potential.

Main Results:

• Successfully generated and validated five human iPSC lines carrying MECP2 duplications.
• Confirmed the pluripotency and differentiation capacity of the generated iPSC lines.
• Established a characterized cellular model for MECP2 Duplication Syndrome.

Conclusions:

• The generated iPSC lines are a robust resource for MECP2 Duplication Syndrome research.
• These cell lines will aid in understanding disease mechanisms and in developing and screening therapeutic strategies.
• This study provides a foundation for future investigations into neurodevelopmental disorders linked to MECP2.